Seal Integrity in Pharmaceutical Blister Packaging

Search

Why Seal Integrity Is a Material-Driven Parameter

Both blister and strip packaging depend on sealed structures for protection.

Blister Packaging

Forming film (PVC or similar)
Aluminum lidding foil with heat-seal coating

Strip Packaging

Laminated aluminum foils (with polymer layers such as LDPE)

In both cases, the seal is only as reliable as the material interface between layers.

Even when sealing parameters are optimized, poor foil quality can lead to:

inconsistent bonding
micro-leakage paths
reduced barrier performance
variability across production batches

For sensitive pharmaceutical formulations, such inconsistencies can result in stability failures and compliance risks.

Seal Strength in Blister Packaging

Blister packaging uses non-peelable seals, where the lidding foil is bonded permanently to the forming film.

The performance of this seal depends largely on the heat-seal coating applied to the aluminum foil.

Critical material-driven factors include:

uniform coating thickness across the foil surface
consistent adhesion properties with the forming film
resistance to channel formation or weak spots
compatibility with different blister substrates (PVC, PVDC, etc.)

Unlike strip packaging, the seal is not designed to be peeled. Instead, it must maintain integrity until the product is accessed via push-through.

Peel Strength in Strip (Laminated) Packaging

Peel strength is a relevant parameter in strip packaging, where laminated foil structures are used.

In these systems, aluminum foil is combined with polymer layers (such as LDPE), enabling controlled peel-open functionality.

Peel strength depends on:

the lamination quality between layers
the polymer composition and thickness
the consistency of bonding across the laminate

A well-designed laminate ensures:

secure sealing during storage and transport
predictable and user-friendly opening

This parameter is specific to laminated strip foils and does not apply to standard blister lidding foils.

Key Foil Properties That Influence Seal Integrity

Seal integrity is highly dependent on the following foil characteristics:

1. Heat-Seal Coating Consistency

The coating layer must be uniform and precisely controlled.

Variations can lead to:

uneven sealing
weak bond areas
increased risk of leakage

2. Coating–Substrate Compatibility

The coating formulation must match the forming film or laminate structure.

Incorrect compatibility may result in:

poor adhesion
seal failure under stress

3. Foil Surface Quality

Surface defects such as pinholes, contamination, or irregularities can compromise sealing.

High-quality foils ensure:

clean, defect-free surfaces
reliable contact during sealing

4. Barrier Properties

Aluminum foil must provide a strong barrier against:

moisture
oxygen
light

Any compromise in barrier integrity increases product vulnerability.

Seal Integrity Testing from a Material Perspective

While testing is performed at the packaging level, results often reflect material performance.

1. Seal Strength Testing (Blister)

Evaluates the bond quality achieved by the foil coating with the forming film.

2. Peel Strength Testing (Strip Packaging)

Measures the separation force in laminated structures, indicating lamination consistency.

3. Dye Penetration & Leak Testing

Helps identify micro-defects that may originate from:

coating inconsistency
surface imperfections
material variability

These tests are essential for validating both material selection and supplier consistency.

Common Material-Related Causes of Seal Failure

Many seal failures originate from foil-related issues rather than process errors:

inconsistent heat-seal coating application
poor coating adhesion properties
variation between production batches
surface contamination or defects
inadequate lamination quality (in strip foils)

Selecting a reliable foil supplier with controlled manufacturing processes significantly reduces these risks.

Regulatory Expectations

Regulatory authorities expect pharmaceutical companies to ensure that packaging materials consistently meet defined performance standards.

This includes:

qualification of packaging materials
validation of sealing performance
documentation of material specifications

Foil quality, coating consistency, and supplier reliability are therefore critical components of regulatory compliance.

Role of High-Quality Foils in Packaging Reliability

Consistent seal integrity is not achieved by process control alone—it requires high-quality, precisely engineered aluminum foils.

Pharmaceutical-grade foils should offer:

uniform heat-seal coating
reliable bonding performance
excellent barrier protection
batch-to-batch consistency

These attributes enable stable sealing performance across high-speed production lines and global supply chains.

Strengthening Seal Integrity Through Material Excellence

Seal integrity is a fundamental requirement in pharmaceutical packaging. While sealing parameters and equipment play a role, material quality—especially aluminum foil performance—is a primary driver of reliability.

By selecting the right foil structures, ensuring coating compatibility, and maintaining strict quality standards, manufacturers can significantly reduce packaging risks.

Strong seal integrity helps:

protect product stability
minimize recalls and complaints
meet global regulatory requirements
ensure patient safety

Sanwariya Packaging supports these outcomes by supplying pharmaceutical aluminum foils designed for consistent coating performance, reliable sealing compatibility, and high barrier protection. With controlled manufacturing processes and strict quality standards, Sanwariya Packaging enables pharmaceutical companies to achieve dependable packaging performance at scale.

Turn Insights Into Actions
— spread awareness and drive meaningful change.

Related Blogs

Serialization updates for printed foils in 2026

Medicines are carefully formulated to remain stable and effective throughout their shelf life. However, some pharmaceutical compounds are highly sensitive to light, particularly ultraviolet (UV) radiation. When exposed to light, these medicines may undergo chemical degradation that reduces potency or alters their safety profile.

Because of this risk, protecting medicines from light exposure is an important consideration during pharmaceutical packaging design. Packaging materials must shield sensitive formulations from harmful wavelengths while maintaining stability during storage, transportation, and distribution.

Blister packaging using aluminum-based foils plays a significant role in protecting light-sensitive medicines. The reflective properties of aluminum, combined with specialized coatings, help prevent ultraviolet radiation from reaching the drug product.

This blog explains the science of UV degradation, how aluminum foil provides light protection, the testing methods used to validate UV resistance, and how pharmaceutical companies select the most appropriate foil structures for light-sensitive medicines.

Why Light Exposure Can Damage Medicines

Many pharmaceutical ingredients are sensitive to electromagnetic radiation within the ultraviolet and visible light spectrum. When exposed to light, the energy absorbed by the molecule can trigger chemical reactions that alter the structure of the active ingredient.

These reactions may lead to several types of degradation.

Loss of drug potency
Formation of degradation by-products
Color changes in the formulation
Reduced shelf life or stability

Certain categories of medicines are particularly vulnerable to photodegradation. These may include antibiotics, vitamins, biological compounds, and formulations containing complex organic molecules.

Even limited exposure during transportation or storage can contribute to gradual degradation if packaging does not provide adequate protection.

For this reason, stability studies often include light exposure testing to determine whether protective packaging is required.

Understanding UV Degradation in Pharmaceutical Stability

Photodegradation occurs when molecules absorb photons from light energy. Ultraviolet radiation carries higher energy compared with visible light, making it especially capable of breaking chemical bonds.

In pharmaceutical stability studies, exposure to light can cause molecular reactions such as oxidation, isomerization, or structural breakdown of active ingredients.

The likelihood of degradation depends on several factors.

Wavelength of the incoming light
Duration of exposure
Sensitivity of the drug molecule
Transparency of the packaging material

Packaging materials that allow UV light to pass through may expose the product to degradation risks over time. As a result, selecting materials with strong UV-blocking properties is an important part of packaging development for light-sensitive medicines.

How Aluminum Foil Acts as a UV Barrier

Aluminum foil provides one of the most effective barriers against light exposure in pharmaceutical packaging. Unlike transparent or translucent materials, aluminum reflects and blocks a large portion of incoming radiation.

The metal surface reflects both visible and ultraviolet wavelengths, preventing light from reaching the medicine inside the blister cavity.

This reflective behavior provides several advantages.

Near-complete opacity to light
Strong UV blocking capability
Stable protection across different wavelengths
Consistent performance during storage and transport

Because of these properties, aluminum foil is widely used in blister foils for light-sensitive formulations.

When combined with appropriate coatings and printing layers, foil structures can maintain both functional protection and regulatory labeling requirements.

Reflectivity Advantage of Aluminum in Pharmaceutical Packaging

The reflective surface of aluminum plays a key role in reducing UV penetration. When ultraviolet radiation strikes the foil surface, a significant portion of the energy is reflected away instead of passing through the material.

This reflective behavior helps maintain a stable internal environment for the medicine.

The performance of the foil barrier can be influenced by factors such as:

Foil thickness
Coating layers applied to the surface
Printing inks and pigments
Surface finish of the foil

Higher-quality foil structures maintain consistent reflectivity while also supporting reliable printing and sealing performance.

This combination of mechanical strength and optical protection makes aluminum foil particularly suitable for medicines that require strict light protection, including advanced structures like cold forming foils and multi-layer foils.

Testing Light Protection in Pharmaceutical Packaging

Pharmaceutical companies must demonstrate that packaging materials adequately protect light-sensitive medicines throughout the product’s shelf life.

This evaluation is typically performed during stability testing under controlled laboratory conditions.

Common testing approaches include:

Exposure to defined ultraviolet and visible light levels
Accelerated stability testing with controlled light sources
Measurement of degradation products after exposure
Comparison of protected and unprotected samples

International stability guidelines often define the total light exposure conditions required for photostability testing.

These tests help determine whether the selected packaging structure provides sufficient UV protection for the medicine.

If degradation is observed, packaging engineers may modify the material structure or increase the protective barrier properties.

Selecting the Right Foil Coating for UV Protection

While aluminum itself provides strong light protection, coatings and printing layers applied to the foil can influence overall performance.

Coatings are often applied to support sealing, printing, or machine compatibility. However, these coatings must also maintain the protective characteristics of the foil.

Packaging development teams evaluate several coating-related factors.

Compatibility with blister sealing processes
Resistance to environmental exposure
Stability of printed graphics during storage
Maintenance of UV-blocking performance

Specialized coatings may also reduce surface reflections that could interfere with printing or scanning technologies while maintaining the underlying barrier performance.

Selecting the correct coating system ensures that the foil continues to provide effective UV protection throughout the product lifecycle.

Challenges When Shipping Light-Sensitive Medicines Globally

Medicines distributed internationally may encounter a wide range of environmental conditions during transportation. Products shipped to regions with strong sunlight or high ambient temperatures may experience greater light exposure during handling and storage.

Export-oriented pharmaceutical companies therefore evaluate packaging carefully when shipping to high-exposure markets.

Potential risks during distribution include:

Prolonged exposure to sunlight during logistics handling
Storage in brightly lit warehouse environments
Transportation through regions with intense solar radiation

Using packaging materials with strong light barrier properties helps reduce these risks and ensures that medicines remain stable until they reach patients.

Regulatory Expectations for Photostability Protection

Global pharmaceutical regulators expect companies to demonstrate that packaging materials adequately protect medicines from environmental factors such as light, moisture, and oxygen.

Photostability studies form part of the broader stability testing framework used to establish shelf life.

Regulatory documentation may include:

Photostability study reports
Packaging material specifications
Validation of protective packaging performance
Long-term stability data under recommended storage conditions

Maintaining thorough documentation helps ensure compliance during regulatory submissions and inspections.

Packaging materials must therefore be selected not only for functional performance but also for their ability to support documented stability outcomes.

Ensuring Stability for Light-Sensitive Medicines

Protecting medicines from ultraviolet radiation is an essential aspect of pharmaceutical packaging design. Exposure to light can cause chemical degradation that affects both product efficacy and safety.

Aluminum blister foils provide an effective solution by reflecting and blocking ultraviolet radiation before it reaches the medicine. When combined with appropriate coatings and carefully designed packaging structures, these materials help maintain stability throughout the product’s lifecycle.

For pharmaceutical companies developing light-sensitive formulations, selecting the right packaging materials is a critical step in ensuring long-term product quality and regulatory compliance.

Sanwariya Packaging manufactures pharmaceutical aluminum foils designed to provide strong barrier protection, reliable printing performance, and compatibility with modern blister packaging systems. Through controlled manufacturing processes and advanced capabilities supported by its infrastructure, Sanwariya Packaging supports pharmaceutical companies in developing packaging solutions that help protect sensitive medicines throughout global distribution.For further discussions or requirements, you can get in touch with us or directly request a quote.

The Proven Way to Protect Light-Sensitive Medicines

Peel strength and seal performance in pharma blisters

Printed aluminum foils used in pharmaceutical blister packaging such as Blister Foils do more than protect medicines. They also carry critical information that patients, pharmacists, and healthcare professionals rely on every day. Batch numbers, expiry dates, dosage instructions, and regulatory warnings must remain clearly visible throughout the product’s life cycle.

Because of this, the surface finish of printed foil plays an important role in pharmaceutical packaging design. The finish affects how easily text can be read, how the package appears under different lighting conditions, and how comfortably patients can handle the medicine.

Today, packaging teams increasingly evaluate different printed foil finish pharma options—including gloss, matte, and satin surfaces—to ensure optimal readability, usability, and regulatory print clarity.

This blog explains the main types of foil finishes used in pharmaceutical packaging and how they influence patient usability and packaging performance.

Why Foil Surface Finish Matters in Pharmaceutical Packaging

Pharmaceutical blister foils must balance multiple requirements at the same time:

clear printing of product information
resistance to smudging or abrasion
readability under different lighting conditions
compatibility with packaging equipment
compliance with regulatory labeling standards

The foil finish influences how printed text appears on the package. It can affect:

glare and reflection
contrast between background and text
ease of reading small printed characters
durability of the printed layer

For medicines that are frequently handled—such as daily prescription tablets—these factors become especially important. Poor readability or excessive glare may make it difficult for patients to read essential information printed on the blister foil.

Understanding the Main Types of Printed Foil Finishes

Pharmaceutical packaging typically uses three common types of foil finishes: gloss, matte, and satin. Each offers different visual and functional characteristics.

Gloss Foil Finish

Gloss finishes create a smooth, reflective surface that gives the foil a bright and polished appearance.

This finish is often used when packaging design requires vibrant colors and strong visual contrast. The reflective surface enhances color depth and makes printed graphics appear more vivid.

Key characteristics of gloss finishes

high surface shine and reflectivity
strong color brightness
visually striking packaging appearance
smooth surface texture

While gloss finishes can enhance brand visibility, they may also produce glare under strong lighting conditions. In some environments—such as pharmacies or hospitals with bright lighting—reflection from glossy surfaces may slightly reduce text readability.

Because of this, packaging teams often carefully evaluate gloss finishes when small regulatory text or dosage instructions must remain clearly visible.

Matte Foil Finish

Matte finishes provide a non-reflective surface that diffuses light rather than reflecting it. This creates a softer appearance and significantly reduces glare.

Matte surfaces are often preferred when print clarity and readability are primary priorities.

Key characteristics of matte finishes

low reflectivity
reduced glare under bright lighting
excellent readability for small text
subtle, non-shiny appearance

In pharmaceutical packaging, matte finishes are commonly selected for products that contain detailed labeling or extensive regulatory information.

Because the surface reduces reflections, it can make printed characters easier to read from different viewing angles.

Satin Foil Finish

Satin finishes offer a balance between gloss and matte surfaces. They provide a moderate level of shine while still controlling excessive glare.

This finish creates a smooth and refined appearance without the high reflectivity associated with gloss coatings.

Key characteristics of satin finishes

moderate surface sheen
balanced reflectivity
improved readability compared with high-gloss surfaces
premium visual appearance

Satin finishes are often chosen when packaging teams want a combination of strong visual appeal and improved usability.

They are particularly suitable for pharmaceutical brands that aim to maintain both aesthetic packaging design and practical readability.

Anti-Glare Considerations in Pharmaceutical Packaging

Glare is an important usability factor that packaging teams evaluate when selecting foil finishes.

Highly reflective surfaces may produce bright reflections when exposed to strong lighting. This can make it harder to read small printed text, particularly for patients with reduced vision.

Reducing glare improves packaging usability in several ways:

easier reading of dosage instructions
clearer visibility of expiry dates and batch numbers
better legibility in pharmacies and hospitals
improved accessibility for elderly patients

Because patient safety depends on accurate reading of packaging information, many pharmaceutical companies consider anti-glare properties when choosing foil finishes.

Regulatory Expectations for Print Clarity

Regulatory authorities around the world require that pharmaceutical packaging information remain clear, legible, and durable.

Labeling on blister foils typically includes critical information such as:

medicine name
dosage strength
batch number
manufacturing date
expiry date
regulatory symbols or warnings

If printing becomes difficult to read due to glare, poor contrast, or surface reflection, it may create compliance concerns during regulatory inspections.

As a result, regulatory affairs teams often work closely with packaging development teams when selecting foil finishes that support clear and compliant labeling.

Balancing Usability and Brand Presentation

In addition to regulatory requirements, pharmaceutical companies also consider the visual appearance of packaging.

Different foil finishes can influence how a product is perceived by patients and healthcare professionals.

For example:

gloss finishes may enhance brand recognition through vibrant colors
matte finishes emphasize clarity and professional simplicity
satin finishes combine visual appeal with practical readability

The final selection typically depends on the product category, branding strategy, and labeling requirements.

For medicines intended for long-term treatment or daily use, usability considerations often become the primary factor guiding finish selection.

Factors Packaging Teams Consider When Choosing Foil Finishes

Packaging development teams usually evaluate several technical and usability factors before finalizing a printed foil finish.

These may include:

readability of printed text under different lighting conditions
compatibility with printing processes
resistance to abrasion during handling
performance during blister sealing operations
regulatory labeling requirements across export markets

Testing printed samples under real-world conditions helps ensure that the chosen finish performs consistently during packaging, distribution, and patient use.

Supporting Patient-Friendly Pharmaceutical Packaging

The surface finish of printed blister foil may appear to be a small design detail, but it plays an important role in the usability and effectiveness of pharmaceutical packaging.

Selecting the right printed foil finish pharma option helps companies:

improve readability of critical product information
reduce glare that may affect patient usability
maintain regulatory labeling clarity
enhance the overall appearance of pharmaceutical packaging

By carefully balancing visual design with practical functionality, pharmaceutical companies can create packaging that supports both patient safety and brand presentation.

Sanwariya Packaging manufactures pharmaceutical aluminum foils with a range of printed finish options designed to support clear labeling, reliable printing performance, and consistent packaging quality. Through controlled manufacturing processes and advanced capabilities supported by its infrastructure, Sanwariya Packaging helps pharmaceutical companies develop packaging solutions that combine regulatory compliance with patient-friendly usability.

For further details or project discussions, you can get in touch with us or directly request a quote.

Discover the Best Foil Finish for Safer Patient Packaging

Stricter global standards for packaging surface cleanliness

Pharmaceutical packaging is often seen as the final stage of medicine production. In reality, it plays a crucial role in protecting medicines from contamination and preserving their quality until they reach the patient.

Even when medicines are manufactured under highly controlled conditions, contamination risks can still arise if packaging materials carry dust, fibers, or microscopic particles. Because of this, regulators and pharmaceutical companies around the world are paying closer attention to pharma packaging surface cleanliness.

Over the past decade, expectations surrounding packaging hygiene, particulate control, and clean handling practices have become significantly stricter. The goal is simple: prevent contamination before it reaches the patient.

This blog explains why packaging cleanliness standards are tightening globally, the risks associated with particulate contamination, and how pharmaceutical companies are adapting their packaging practices to meet evolving Good Manufacturing Practice (GMP) expectations across modern pharmaceutical packaging materials.

Why Packaging Surface Cleanliness Matters

Packaging materials frequently come into direct contact with medicines or the environment surrounding them during packaging operations. If the surface of the packaging carries particles or residues, those contaminants can easily reach the product.

Common sources of contamination include:

Dust introduced during storage or transportation
Fibers from packaging materials or operator clothing
Residues from manufacturing or converting processes
Environmental particles present in production areas

Even extremely small particles can create problems during pharmaceutical packaging.

For example: particles may become trapped inside blister cavities, appear as visible contaminants in finished products, or interfere with sealing processes used withblister foils.

For pharmaceutical manufacturers, this creates two major concerns:

Product quality risks
Regulatory inspection observations

As a result, surface cleanliness in pharmaceutical packaging has become a critical component of contamination control strategies.

The Growing Risk of Particulate Contamination

Particles that are barely visible to the human eye can still cause significant problems in pharmaceutical packaging.

During packaging operations, loose particles may:

Enter blister cavities along with tablets or capsules
Prevent proper sealing of blister packs
Appear as visible foreign matter inside the package
Trigger product complaints or recalls

Regulatory authorities treat visible contamination very seriously. Even a single particle found during inspection or market complaints may raise questions about the effectiveness of a company’s contamination control systems.

Because of this, packaging cleanliness is no longer considered a minor operational detail. It is now an essential part of overall pharmaceutical quality management.

Why Global Regulators Are Increasing Expectations

Several industry trends are driving stricter regulatory expectations regarding packaging cleanliness.

1. Increasingly Sensitive Pharmaceutical Formulations

Modern medicines are often more complex and sensitive than traditional formulations. Some drugs can be affected by extremely small environmental contaminants.

Maintaining clean packaging surfaces helps ensure that these sensitive products remain stable and uncontaminated.

2. Expanding Global Supply Chains

Pharmaceutical packaging materials frequently travel long distances before reaching production facilities.

During transport and storage, materials may be exposed to dust, handling environments, or environmental particles. As pharmaceutical supply chains become more global, maintaining packaging cleanliness throughout the entire logistics process becomes more important.

Materials such as strip laminated foils and PVC foils must therefore be handled carefully to maintain their cleanliness during transportation and storage.

3. Preventive Quality Approaches

Regulators now emphasize preventing contamination rather than detecting it later.

Instead of relying only on inspection, companies are expected to demonstrate that their processes minimize contamination risks from the beginning. This includes how packaging materials are manufactured, stored, transported, and handled.

The Role of Cleanroom and Environmental Control Standards

Many pharmaceutical companies use internationally recognized environmental control frameworks when developing contamination control programs.

These frameworks focus on:

Monitoring airborne particle levels
Defining acceptable environmental cleanliness limits
Establishing controlled handling procedures
Implementing environmental monitoring systems

While these principles are traditionally associated with cleanrooms used in pharmaceutical manufacturing, similar concepts are increasingly applied to packaging material production and handling.

For packaging suppliers, this means demonstrating that their materials are produced and handled under conditions that minimize contamination risks within well-controlled manufacturing infrastructure.

Cleanroom-Compatible Handling for Packaging Materials

As expectations increase, many pharmaceutical companies now request packaging materials that are produced or handled in environments designed to control particulate contamination.

Cleanroom-compatible handling practices typically focus on controlling:

Airborne dust and environmental particles
Operator contact with materials
Contamination from surrounding manufacturing processes
Storage and packaging conditions during production

These controls help ensure that packaging materials arrive at pharmaceutical manufacturing sites in a clean and ready-to-use condition.

For pharmaceutical manufacturers, receiving clean packaging materials reduces the risk of contamination entering the packaging process.

Maintaining Cleanliness During Pharmaceutical Packaging Operations

Even when packaging materials arrive clean from suppliers, pharmaceutical manufacturers must maintain that cleanliness throughout their internal operations.

Production teams typically implement several procedures to prevent contamination during packaging.

Common practices include:

Dedicated storage areas for packaging materials
Protective coverings during internal transport
Line clearance procedures before packaging runs
Controlled handling by trained operators
Regular cleaning of packaging equipment and work areas

These procedures help maintain a controlled environment where contamination risks remain minimal.

Why Supplier Qualification Is Becoming More Important

Because many pharmaceutical packaging materials are sourced from external suppliers, pharmaceutical companies must verify that those suppliers maintain appropriate cleanliness standards.

Supplier qualification programs often review:

Manufacturing hygiene practices
Environmental control systems within production facilities
Material handling procedures
Storage and transportation methods
Documentation supporting traceability and cleanliness controls

This verification process helps pharmaceutical companies ensure that contamination risks are minimized before packaging materials even reach their facilities.

Strong supplier qualification programs also play an important role during regulatory inspections.

Export Markets Are Raising the Cleanliness Bar

Pharmaceutical companies supplying medicines to multiple countries must often comply with the strictest quality expectations among those markets.

Regulatory authorities may review contamination control strategies during inspections or dossier evaluations. As a result, packaging cleanliness documentation and supplier quality systems are becoming increasingly important for companies entering global markets.

Export-focused pharmaceutical manufacturers are therefore strengthening packaging hygiene standards to ensure consistent compliance across regulatory environments.

Clean Packaging Supports Patient Safety and Trust

Stricter packaging cleanliness standards ultimately support a broader objective: protecting patients and maintaining trust in pharmaceutical products.

Clean packaging surfaces help pharmaceutical companies:

Prevent contamination during packaging operations
Reduce the risk of visible particles in finished products
Improve batch consistency and product quality
Demonstrate strong contamination control during regulatory inspections

For quality assurance and compliance teams, maintaining high standards of pharma packaging surface cleanliness is now an essential part of modern pharmaceutical manufacturing.

How Sanwariya Packaging Supports Clean Pharmaceutical Packaging

Sanwariya Packaging manufactures pharmaceutical aluminum foils with strong attention to controlled production, material hygiene, and consistent quality processes. Our manufacturing practices are designed to support high standards of pharma packaging surface cleanliness, helping pharmaceutical manufacturers reduce contamination risks during packaging operations.

Through carefully controlled production environments, specialized packaging materials such as cold forming foils and hologram security foils, and strong process control, we support pharmaceutical companies in maintaining product integrity and meeting global regulatory expectations.

Companies interested in exploring suitable pharmaceutical packaging solutions can get in touch with us or directly request a quote for customized foil packaging materials.

Essential Guide to Better Seal Integrity in Pharma Packaging